Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

SEC Filings Just Revealed the Smart Money Is Overweight SpaceX. Should You Buy It Now?

SEC Filings Just Revealed the Smart Money Is Overweight SpaceX. Should You Buy It Now?

Space Exploration Technologies (SPCX) went public in mid-June, raising $86 billion and valuing the company at approximately $1.77 trillion. Institutional investors, mandated to disclose stakes in the company on their quarterly 13F filings, revealed that 1,932 13F filings included $611 billion in holdings of SpaceX shares. Alphabet, Fidelity Investments, and Valor Management were among the early investors, with significant stakes in the company.

While there is an indication that smart money is overweight in SpaceX relative to the market, the actions of large institutional investors remain a key data point for investors to consider.

Written by urgent.news from Yahoo Finance's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at finance.yahoo.com →

More in Finance & Markets

Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.

  • Amgen is a global pharmaceutical giant with operations in 100+ countries
  • Axsome Therapeutics specializes in CNS disorders like depression and narcolepsy
  • Amgen's revenue heavily concentrated in 3 distributors, introducing risk

More from Saturday 29 August →